Results 161 to 170 of about 7,376,780 (336)

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

The path to adoption of open source AI for drug discovery in Africa

open access: yesArtificial Intelligence in the Life Sciences
Gemma Turon, Miquel Duran-Frigola
doaj   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

An Open-Source, Low-Cost Solution for 3D Scanning. [PDF]

open access: yesSensors (Basel)
Mateescu A   +3 more
europepmc   +1 more source

Open source health systems [PDF]

open access: yes, 2005
Forslund, D, Kalra, D
core  

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Open Source & Open Data

open access: yes, 2019
Proyectos de Código Abierto (Open Source) y de Acceso Abierto (Open Access) han definido y siguen dando forma a grandes desarrollos en la ciencia fundamental y las tecnologías de la información.Desde hace mucho tiempo, pero más aun hoy en día, empresas científicas y colaboraciones académicas impulsan un basto set de proyectos Open Source en términos de
openaire   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

GARDE-Chat: a scalable, open-source platform for building and deploying health chatbots. [PDF]

open access: yesJ Am Med Inform Assoc
Del Fiol G   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy